Advisory

We make your sustainability efforts measurable, actionable & impactful

We are seasoned management consultants with extensive experience from serving established companies, institutional investors, and public institutions on their most pressing topics within strategy, organisation and sustainability. Bringing with us hands-on experience as managers and executives.

image-a57ad21139f612256914f4fecedb68bc2dcfb81c-7889x5262-jpg

We support clients driving sustainability forward from any starting point

We are seasoned management consultants with extensive experience from serving established companies, institutional investors, and public institutions on their most pressing topics within strategy, organisation and sustainability.

Read more about Our services
01ensuring compliance
02minimising business risks
03exploring opportunities
04reshaping company purpose
05transforming business

Our services cover every step of the sustainability journey — from ambition to action

View all services about Our services

Our advisory cases

We work with private companies, government institutions, investors, funds and foundations in both crafting and realising their full sustainability potential. We are industry agnostic and advise companies of varying size both in the Nordics and globally.

See all about Our cases
The Footprint Firm Advisory

Looking to accelerate your sustainability transition? Take a look at our featured advisory services

Learn moreabout Our services

Advisory

We partner with companies and organisations to turn sustainability ambitions into measurable, actionable impact.

Learn more about Our services
image-ed31609b779a7ec0aeec619c59067a44ca013678-720x840-png

Novo Nordisk

ESG industry reporting benchmark

Novo Nordisk is a global healthcare leader with a longstanding commitment to sustainability. To stay ahead in a rapidly evolving ESG landscape, Novo Nordisk partnered with The Footprint Firm to strengthen the company’s ESG reporting strategy, ensuring alignment with best practices, regulatory expectations, and stakeholder needs across the pharmaceutical sector and beyond.

image-fc2ff91ec16a268119abf698f98ce6025d95ebaf-568x400-png

Services

Industries

  • Pharmaceuticals & healthcare
The project

Novo Nordisk sought to define a forward-looking strategy for ESG reporting and disclosures. The goal was to benchmark industry peers and adjacent sectors, assess alignment with leading standards and frameworks, and ultimately shape a robust reporting approach that supports transparency and trust with a wide range of stakeholders.

Our approach

We began by developing a best-practice ESG reporting framework grounded in existing standards and regulation, including a detailed benchmark of ESG disclosures from peers and selected leaders outside the pharmaceutical industry.


In the second phase, we facilitated discussions with Novo Nordisk to refine the company’s level of ESG ambition, identify material topics, and explore how to meet the information needs of diverse stakeholder groups, from patients and NGOs to rating agencies and the general public.


We also conducted a review of Novo Nordisk’s available data against the requirements of leading frameworks and supported the development of governance processes to strengthen ESG reporting going forward.

The impact

Our collaboration has helped Novo Nordisk take a strategic and structured approach to ESG reporting, grounded in industry benchmarks, stakeholder relevance, and future regulatory readiness.

The resulting framework and governance setup position Novo Nordisk to deliver transparent, consistent, and stakeholder-informed ESG disclosures in an increasingly complex reporting environment.